Pablo Roitman

834 total citations
22 papers, 606 citations indexed

About

Pablo Roitman is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Oncology. According to data from OpenAlex, Pablo Roitman has authored 22 papers receiving a total of 606 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 9 papers in Rheumatology and 8 papers in Oncology. Recurrent topics in Pablo Roitman's work include Sarcoma Diagnosis and Treatment (9 papers), Bone Tumor Diagnosis and Treatments (7 papers) and Oral and Maxillofacial Pathology (4 papers). Pablo Roitman is often cited by papers focused on Sarcoma Diagnosis and Treatment (9 papers), Bone Tumor Diagnosis and Treatments (7 papers) and Oral and Maxillofacial Pathology (4 papers). Pablo Roitman collaborates with scholars based in Argentina, Israel and United States. Pablo Roitman's co-authors include Arieh Y. Shalev, Luis A. Aponte-Tinao, Germán L. Farfalli, Raphael Mechoulam, Rena Cooper‐Kazaz, Moran Gilad, Nicolás S. Piuzzi, Yael L. E. Ankri, Isaac R. Galatzer‐Levy and Sara Freedman and has published in prestigious journals such as PLoS ONE, Scientific Reports and Clinical Orthopaedics and Related Research.

In The Last Decade

Pablo Roitman

20 papers receiving 599 citations

Peers

Countries citing papers authored by Pablo Roitman

Since Specialization

Citations

This map shows the geographic impact of Pablo Roitman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pablo Roitman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pablo Roitman more than expected).

Fields of papers citing papers by Pablo Roitman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pablo Roitman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pablo Roitman. The network helps show where Pablo Roitman may publish in the future.

Co-authorship network of co-authors of Pablo Roitman

This figure shows the co-authorship network connecting the top 25 collaborators of Pablo Roitman. A scholar is included among the top collaborators of Pablo Roitman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pablo Roitman. Pablo Roitman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Atypical spindle cell lipomatous tumor of the perineum 2025 ·Radiology Case Reports ·(unknown), P. Troncoso, (unknown), (unknown), J. Manuel Sarmiento, (unknown), (unknown), Pablo Roitman, (unknown)	0
2	Intraoperative frozen section analysis for detection of fracture-related infection in nonunion of the upper limb. Diagnostic accuracy study 2024 ·Injury ·E. Martinez, (unknown), (unknown), (unknown), (unknown), Pablo De Carli, Pablo Roitman, Jorge Albores‐Saavedra	1
3	Pseudomyogenic hemangioendothelioma with bone and soft tissue involvement with favorable response to pamidronate: a case report and systematic review of the literature 2022 ·Archives of Osteoporosis ·María Lorena Brance, (unknown), Pablo Roitman, (unknown), (unknown), (unknown), (unknown), (unknown), Lucas R. Brun	6
4	Profiling of three H3F3A-mutated and denosumab-treated giant cell tumors of bone points to diverging pathways during progression and malignant transformation 2021 ·Scientific Reports ·(unknown), Kevin Mellert, Ralf Marienfeld, Alexandra von Baer, Markus Schultheiß, Pablo Roitman, Luis A. Aponte-Tinao, Burkhard Lehner, Peter Mӧller, Gunhild Mechtersheimer, Thomas F.E. Barth	15
5	[Denosumab as a treatment for giant cell tumor of bone. Indications, results and side effects]. 2021 ·PubMed ·(unknown), José I. Albergo, Germán L. Farfalli, Pablo Roitman, Luisa Plantalech, Miguel A. Ayerza, Luis A. Aponte-Tinao	2
6	Sarcoma de ewing óseo. Enfoque multidisciplinario y resultados oncológicos en 88 pacientes 2020 ·Medicina-buenos Aires ·(unknown), (unknown), José I. Albergo, Germán L. Farfalli, (unknown), Miguel A. Ayerza, (unknown), (unknown), Marcelo Risk, Pablo Roitman	0
7	Does Osteoarticular Allograft Reconstruction Achieve Long-term Survivorship after En Bloc Resection of Grade 3 Giant Cell Tumor of Bone? 2020 ·Clinical Orthopaedics and Related Research ·José I. Albergo, Germán L. Farfalli, (unknown), Pablo Roitman, Miguel A. Ayerza, Luis A. Aponte-Tinao	4
8	Pseudomyogenic Hemangioendothelioma (Epithelioid Sarcoma-Like Hemangioendothelioma) 2019 ·Archives of Pathology & Laboratory Medicine ·(unknown), Pablo Roitman	9
9	Nodular fasciitis, a forgotten entity 2018 ·International Journal of Dermatology ·(unknown), (unknown), (unknown), (unknown), (unknown), Pablo Roitman, Gastón Galimberti, Luis Daniel Mazzuoccolo	14
10	Denosumab-treated giant cell tumor of bone. Its histologic spectrum and potential diagnostic pitfalls 2017 ·Human Pathology ·Pablo Roitman, (unknown), Germán L. Farfalli, José I. Albergo, Luis A. Aponte-Tinao	39
11	Foreign-Body Reaction and Osteolysis in Dorsal Lunate Dislocation Repair With Bioabsorbable Suture Anchor 2016 ·Hand ·(unknown), Pablo Roitman, Gerardo Gallucci, Jorge G. Boretto, Pablo De Carli	7
12	Is Needle Biopsy Clinically Useful in Preoperative Grading of Central Chondrosarcoma of the Pelvis and Long Bones? 2016 ·Clinical Orthopaedics and Related Research ·Pablo Roitman, Germán L. Farfalli, Miguel A. Ayerza, Luis D. Múscolo, (unknown), Luis A. Aponte-Tinao	53
13	A High-grade Sarcoma Arising in a Patient With Recurrent Benign Giant Cell Tumor of the Proximal Tibia While Receiving Treatment With Denosumab 2015 ·Clinical Orthopaedics and Related Research ·Luis A. Aponte-Tinao, Nicolás S. Piuzzi, Pablo Roitman, Germán L. Farfalli	84
14	Preliminary, Open-Label, Pilot Study of Add-On Oral Δ9-Tetrahydrocannabinol in Chronic Post-Traumatic Stress Disorder 2014 ·Clinical Drug Investigation ·Pablo Roitman, Raphael Mechoulam, Rena Cooper‐Kazaz, Arieh Y. Shalev	145
15	Clinical relevance of galectin-1 expression in non-small cell lung cancer patients 2014 ·Lung Cancer ·María J. Carlini, Pablo Roitman, (unknown), Marı́a Guadalupe Pallotta, (unknown), (unknown), Mariana Salatino, Elisa Bal de Kier Joffé, Gabriel A. Rabinovich, Lydia Puricelli	38
16	Anti-NMDA Receptor Encephalitis Presenting as an Acute Psychotic Episode in a Young Woman: An Underdiagnosed yet Treatable Disorder 2014 ·Case Reports in Psychiatry ·(unknown), Pablo Roitman, Tamir Ben‐Hur, Omer Bonne, Amit Lotan	11
17	Early PTSD Symptom Trajectories: Persistence, Recovery, and Response to Treatment: Results from the Jerusalem Trauma Outreach and Prevention Study (J-TOPS) 2013 ·PLoS ONE ·Isaac R. Galatzer‐Levy, Yael L. E. Ankri, Sara Freedman, (unknown), Pablo Roitman, Moran Gilad, Arieh Y. Shalev	110
18	Head Injury and Loss of Consciousness Raise the Likelihood of Developing and Maintaining PTSD Symptoms 2013 ·Journal of Traumatic Stress ·Pablo Roitman, Moran Gilad, (unknown), Arieh Y. Shalev	30
19	Correction: Early PTSD Symptom Trajectories: Persistence, Recovery, and Response to Treatment: Results from the Jerusalem Trauma Outreach and Prevention Study (J-TOPS) 2013 ·PLoS ONE ·Isaac R. Galatzer‐Levy, Yael L. E. Ankri, Sara Freedman, (unknown), Pablo Roitman, Moran Gilad, Arieh Y. Shalev	20
20	Breast cancer and the stromal factor. The "prometastatic healing process" hypothesis. 2011 ·PubMed ·(unknown), Pablo Roitman, (unknown), Robert Stern	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact